Margareta Norberg

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Effect of pictorial-based information about atherosclerosis on adherence to lifestyle recommendations: results from the VIPVIZA randomised controlled trial.

Effect of pictorial-based information about atherosclerosis on adherence to lifestyle recommendations: results from the VIPVIZA randomised controlled trial.

Journal: Open heart

Published: March 31, 2026

Associations between lifestyle and initiation of cardiovascular preventive medicines in 60-year-olds at low to moderate cardiovascular risk level - a prospective cohort study based on the VIPVIZA-trial.

Associations between lifestyle and initiation of cardiovascular preventive medicines in 60-year-olds at low to moderate cardiovascular risk level - a prospective cohort study based on the VIPVIZA-trial.

Journal: BMC cardiovascular disorders

Published: February 06, 2026

Beliefs about medicines in relation to the initiation of cardiovascular preventive medications during a 3 year follow-up period after inclusion in the VIPVIZA trial: a cohort study.

Beliefs about medicines in relation to the initiation of cardiovascular preventive medications during a 3 year follow-up period after inclusion in the VIPVIZA trial: a cohort study.

Journal: BMJ open

Published: December 23, 2025

Evaluation after delayed and repeated intervention in the VIPVIZA-extended randomized controlled trial: beneficial results 6 years after baseline.

Evaluation after delayed and repeated intervention in the VIPVIZA-extended randomized controlled trial: beneficial results 6 years after baseline.

Journal: European heart journal open

Published: November 03, 2025

When Pills Get a Pass and Lifestyle Treatments Don't: Misapplication of Phase III Logic to Phase IV Evaluation in Health Care.

When Pills Get a Pass and Lifestyle Treatments Don't: Misapplication of Phase III Logic to Phase IV Evaluation in Health Care.

Journal: Journal of evaluation in clinical practice

Published: August 20, 2025

Midlife Mediterranean diet is associated with subclinical carotid atherosclerosis in late midlife.

Midlife Mediterranean diet is associated with subclinical carotid atherosclerosis in late midlife.

Journal: European journal of preventive cardiology

Published: December 06, 2024

The Path for Men from Young Adulthood Results of Cognitive Tests to Subclinical Atherosclerosis at Age 60: The Mediating Role of Socioeconomic Status, Lifestyle and Cardiovascular Disease Risk Factors-Results from a VIPVIZA Study.

The Path for Men from Young Adulthood Results of Cognitive Tests to Subclinical Atherosclerosis at Age 60: The Mediating Role of Socioeconomic Status, Lifestyle and Cardiovascular Disease Risk Factors-Results from a VIPVIZA Study.

Journal: Reviews in cardiovascular medicine

Published: August 28, 2024

Cohort Profile: The Northern Sweden Health and Disease Study (NSHDS).

Cohort Profile: The Northern Sweden Health and Disease Study (NSHDS).

Journal: International journal of epidemiology

Published: June 26, 2024

Associations between emotional support and cardiovascular risk factors and subclinical atherosclerosis in middle-age.

Associations between emotional support and cardiovascular risk factors and subclinical atherosclerosis in middle-age.

Journal: Psychology & health

Published: November 23, 2023

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication-a sub-study of the VIPVIZA RCT.

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication-a sub-study of the VIPVIZA RCT.

Journal: European journal of clinical pharmacology

Published: August 22, 2023

Changes in fasting plasma glucose and subclinical atherosclerosis: A cohort study from VIPVIZA trial.

Changes in fasting plasma glucose and subclinical atherosclerosis: A cohort study from VIPVIZA trial.

Journal: Atherosclerosis

Published: May 31, 2023

The TANSNIP-PESA trial is not the end of the story.

The TANSNIP-PESA trial is not the end of the story.

Journal: European heart journal

Published: March 23, 2023

Showing 1-12 of 92

Last Updated: 09/26/2026